CompaniesCinfa Biotech

Cinfa Biotech

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

268

By Phase

PHASE1: 2

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT02629562
Hover over trial bars to see details

Recent Trials

NCT02912377Lead Sponsor
Immunogenicity and Pharmacodynamic of B12019 and Neulasta® in Healthy Subjects
PHASE1Completed
96 participants
Started: Sep 30, 2016 · Completed: May 31, 2017
NCT02629562Lead Sponsor
Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy Subjects
PHASE1Completed
172 participants
Started: Nov 30, 2015
Related Companies
Mundipharma
acquired